Semaglutide is not recommended for anyone who has a history of medullary thyroid carcinoma (a rare form of thyroid cancer), or a condition called Multiple Endocrine Neoplasia syndrome type 2. Additionally, Semaglutide is not recommended for those with diabetes.
